Arcutis Biotherapeutics’ $192.5 Million Public Stock Offering

Ambrogio Visconti

Latham & Watkins LLP represented Arcutis Biotherapeutics, Inc. in the transaction. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has announced the pricing of its upsized underwritten public offering…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now